Who is sponsoring NCT05426993?

NCT05426993 is sponsored by Gulhane School of Medicine.

What drugs are being tested in NCT05426993?

Interventions in NCT05426993: Complex decongestive physiotherapy.

What condition does NCT05426993 study?

NCT05426993 studies Lymphedema.

Is NCT05426993 still recruiting?

NCT05426993 is currently completed. Last updated 4 December 2023.

Last reviewed 2023-12-04 · How we verify

NCT05426993

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Metabolic Syndrome on Complex Decongestive Physiotherapy Outcomes in Lymphedema Patients

Completed Last updated 4 December 2023

What this trial tests

trial testing Complex decongestive physiotherapy in Lymphedema in 40 participants. Completed in 15 March 2023.

Timeline

15 July 2022

Primary endpoint
15 September 2022

15 March 2023

Quick facts

Lead sponsor	Gulhane School of Medicine
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	15 July 2022
Primary completion	15 September 2022
Estimated completion	15 March 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Complex decongestive physiotherapy

Conditions studied

Lymphedema — all drugs for Lymphedema →

Sponsor

Gulhane School of Medicine

Who can join

Adults 18 to 65, any sex, with Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As a result of our research, investigators could not find any study investigating the effectiveness of complex decongestive physiotherapy (KBF) in lymphedema patients with metabolic syndrome. Therefore, our aim is to compare the effectiveness of KBF in patients with and without metabolic syndrome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A comparative evaluation of the efficacy of complete decongestive therapy in the treatment of unilateral breast cancer-related lymphedema with and without metabolic syndrome.
Pirincci CS, Mete O, Yasa ME, Dalyan M. · · 2024 · cited 3× · PMID 38949715 · DOI 10.1007/s00520-024-08676-z

Verify or expand the search:

Other trials of Complex decongestive physiotherapy

Trials testing the same drug.

NCT04643392 — Physiotherapy Applications in Upper Extremity Lipedema · completed
NCT04286698 — Two Different Physiotherapy Programs in Lymphedema Following Head and Neck Cancer Treatment · NA · completed

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

NCT07489248 — Multimodal Ultrasound for Differentiating Lymphedema and Lipedema · recruiting
NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
NCT06866197 — CONNECT: A Multi-Cohort, Prospective Investigation of the Symani® Surgical System · NA · recruiting

Other Gulhane School of Medicine trials

Trials by the same sponsor.

NCT07383987 — Genital Hygiene, Toilet Behaviors, and LUTS in Normal Weight and Obese Women · recruiting
NCT07356401 — Associations of Cranial Outcomes and Parental Expectations and Satisfaction · recruiting
NCT07374237 — Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients W · completed
NCT07347561 — A Comparison of Myoelectric and Bionic Hands · recruiting
NCT06850428 — Examining the Relationship Between Physical Activity Levels and Chronotype Tendencies in Individuals With Alcohol Depend · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05426993 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gulhane School of Medicine
Last refreshed: 4 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05426993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing